Amide compound, composition containing amide compound, and uses of amide compound

A technology of amide compounds and compositions, which is applied in the field of medicine and can solve problems such as acquired drug resistance

Active Publication Date: 2019-01-01
SHENZHEN TARGETRX INC
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, patients taking AZD9291 still develop symptoms of acquired resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amide compound, composition containing amide compound, and uses of amide compound
  • Amide compound, composition containing amide compound, and uses of amide compound
  • Amide compound, composition containing amide compound, and uses of amide compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] The following synthetic route was used to prepare 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindoline-2-yl)-N-(thiazol-2-yl-5-d)ethyl Amide (compound 11), comprising the following steps:

[0116]

[0117] Step 1: Synthesis of compound 3.

[0118] Add 4mL of methanesulfonic acid to the reaction flask, cool to 0°C, add α-hydroxyhippuric acid (compound 1, 1g, 5.12mmol), add 4-fluoroanisole (646mg, 5.12mmol) at 0°C, and Under stirring for 1 hour, the reactant was slowly added dropwise to ice water, a white solid was washed out, filtered, the filter cake was washed with water, and vacuum-dried to obtain compound 3 (1.3 mg, yield 86.6%), LC-MS (APCI ):m / z=302(M-1) - .

[0119] Step 2: Synthesis of compound 4.

[0120]Add compound 3 (1g, 3.3mmol) to the reaction flask, add 60mL of 6N hydrochloric acid, heat up to 100°C, react for 36 hours, TLC (thin layer chromatography) detects that the raw materials have reacted completely, cool to room temperature, filter, and the filtr...

Embodiment 2

[0134] The following synthetic route was used to prepare 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindoline-2-yl-3-d)-N-(thiazol-2-yl)ethyl Amide (compound 21), comprising the following steps:

[0135]

[0136] Step 1: Synthesis of Compound 12.

[0137] Add compound 4 (2.08g, 1045mmol) to the reaction flask, add methanol 30mL, cool to 0°C, dropwise add thionyl chloride (1.5mL, 20.9mmol) and raise to 75°C after the dropwise addition, react for 3 hours, the raw material After the reaction was complete, concentrated to remove methanol and excess thionyl chloride, added 20 mL of methyl tert-butyl ether to make a slurry to obtain compound 12 (2.15 g, yield 98.4%), LC-MS (APCI): m / z=214 (M +1) + .

[0138] Step 2: Synthesis of Compound 14.

[0139] Add compound 13 (2g, 12mmol) to the reaction flask, add thionyl chloride 10mL at 0°C, reflux for 3 hours, concentrate to remove excess thionyl chloride to obtain compound 14 (2.74g, yield 100%).

[0140] Step 3: Synthesis of Compoun...

Embodiment 3

[0155] The following synthetic route was used to prepare 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindoline-2-y-yl-3,3-d 2 )-N-(thiazol-2-yl)acetamide (compound 25), comprising the following steps:

[0156]

[0157] Step 1: Synthesis of Compound 22.

[0158] Add compound 16 (1g, 2.91mmol) to the reaction flask, add zinc powder (10g, 152mmol) in 5 times, add deuterated acetic acid 10mL, heat up to 110°C and react for 7 hours, TLC detects that the reaction of the raw materials is complete, filter to remove excess Zinc powder, concentrated to remove acetic acid, added ethyl acetate 40mL, washed with saturated sodium bicarbonate solution, concentrated organic phase, and purified by column chromatography to obtain compound 22 (315mg, yield 26.1%), LC-MS (APCI):m / z=332(M+1) + .

[0159] Step 2: Synthesis of Compound 23.

[0160] Add compound 22 (252mg, 0.76mmol) to the reaction flask, add lithium hydroxide (159mg, 3.8mmol), add water (1mL), tetrahydrofuran (5mL), and react at ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses amide compound represented by a formula (I), preparation and uses thereof, specifically an amide compound represented by the formula (I), or a polymorph, a pharmaceutically acceptable salt, a prodrug, a stereoisomer, an isotope variant, a hydrate or a solvate thereof, a pharmaceutical composition containing the compound, and uses of the compound. According to the present invention, the amide compound and the composition containing the compound can well inhibit protein kinase, have good pharmacokinetic parameter characteristics, and can improve the drug concentration of the compound in the animal so as to improve the treatment effect and the safety of the drug. The formulas I is defined in the specification.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to an amide compound, a composition containing the compound and its application. Background technique [0002] Protein tyrosine kinases play important roles in cellular regulation and their aberrant expression or mutations have been observed in cancer cells or autoimmune diseases. Protein tyrosine kinases are enzymes that catalyze the transport of phosphate groups from ATP to tyrosine located on protein substrates. Many growth factor receptor proteins function as tyrosine kinases to transmit cellular signals. Interactions between growth factors and their receptors normally control cell growth, but aberrant signaling caused by mutation or overexpression of any of the receptors often induces a variety of cancers or autoimmune diseases (such as rheumatoid arthritis inflammation). [0003] EGFR tyrosine kinase inhibitor (EGFR-TKI) is a molecularly targeted drug against E...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12A61P29/00A61P31/00A61P37/00A61P31/12A61P9/00A61P3/00A61P35/00A61P19/02A61P19/06A61P11/06A61P11/02A61P11/08A61P11/00A61K31/426
CPCA61P3/00A61P9/00A61P11/00A61P11/02A61P11/06A61P11/08A61P19/02A61P19/06A61P29/00A61P31/00A61P31/12A61P35/00A61P37/00C07B2200/05C07D417/12A61K31/4035A61K31/426A61K31/427C07D209/34
Inventor 王义汉赵九洋
Owner SHENZHEN TARGETRX INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap